QCM Cayman’s Bio-Techne TECH Stock Holding History

QCM Cayman’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,856	Closed	-$227K	–	283
2020 Q4	$227K	Buy	+2,856	New	+$207K	0.23%	189

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

QCM Cayman's TECH Position: Q1 2021 in Review

QCM Cayman sold out of Bio-Techne (TECH) in Q1 2021, closing a stake of 2,856 shares — an estimated $227K sold.

QCM Cayman first reported a position in TECH in Q4 2020 and held it in 1 quarter. The position peaked at $227K in Q4 2020. 470 funds tracked by Wall St. Rank hold TECH as of Q1 2021.

QCM Cayman reported no remaining Bio-Techne position as of Q1 2021 after selling out during the quarter.
QCM Cayman sold 2,856 Bio-Techne shares in Q1 2021, an estimated $227K.
QCM Cayman first reported a position in Bio-Techne in Q4 2020 and held it in 1 quarter.
QCM Cayman's Bio-Techne position peaked at $227K in Q4 2020.
470 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2021.

Based on QCM Cayman's 13F filing for Q1 2021, filed 17 May 2021.